Parkinson’s treatment targeted in latest pay-for-delay suit
Two generic manufacturers have sued speciality prescription companies US WorldMeds, Supernus and Britannia Pharmaceuticals for allegedly maintaining an unlawful monopoly over a Parkinson’s disease medication.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10